Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta and WBRT in NSCLC brain metastases
NCT00280748Phase 2Terminated
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- May 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), brain metastasis (BM), sponsored by UNC Lineberger Comprehensive Cancer Center. Started May 2005; status: terminated.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)brain metastasis (BM)
Beyond the preview
Go deeper on NCT00280748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280748.